Supplier Page from Cayman Chemical for CAY10574
Ki, IC, EC, or working concentration: IC50: 0.35 µM for CDK9 in vitroKi: 13.3 µM for CDK2-cyclin E with respect to ATPIC50: 20 µM for CDK2-cyclin E with respect to ATPIC50: 33 µM for proliferation of MCF7 cancer cell lineIC50: 49 µM for proliferation of HOS cancer cell lineIC50: 64 µM for proliferation of G361 cancer cell lineIC50: 62 µM for proliferation of K562 cancer cell line